1
Participants
Start Date
February 28, 2015
Primary Completion Date
August 31, 2015
Study Completion Date
August 31, 2015
Gadoxetate disodium (Eovist/Primovist, BAY86-4873)
Participants to receive single dose of Eovist/Primovist as a manual injection at a dose of 0.1 milliliter per kilogram (mL/kg) body weight (BW) (0.025 millimole \[mmol\]/kg BW), followed by a flush of at least 5 mL saline (sodium chloride 0.9 percent \[%\] solution) manually.
New York
Brooklyn
Philadelphia
Washington D.C.
Cincinnati
Madison
Palo Alto
Seattle
Los Angeles
Lead Sponsor
Bayer
INDUSTRY